Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting

被引:25
作者
Lee, Kyung Dong [1 ]
Choi, Seon-Hee [2 ]
Kim, Da Hye [3 ]
Lee, Hye-Young [4 ]
Choi, Ki-Choon [5 ]
机构
[1] Dongsin Univ, Dept Oriental Med Mat, Naju 520714, South Korea
[2] Pusan Natl Univ, Sch Med, Dept Med Sci, Yangsan 626770, Gyeonnam, South Korea
[3] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane, Japan
[4] Yeonsung Univ, Dept Beauty Stylist, Anyang 430749, Gyeonggido, South Korea
[5] Rural Dev Adm, Natl Inst Anim Sci, Grassland & Forages Res Ctr, Cheonan 331808, Chungnam, South Korea
关键词
Folic acid; Dextran succinate; Polyelectrolyte complex; Chitosan; Nanoparticle; IRON-OXIDE NANOPARTICLES; TRANS-RETINOIC ACID; INCORPORATED NANOPARTICLES; ANTITUMOR-ACTIVITY; DELIVERY; MICELLES; CARRIER; AGENT;
D O I
10.1007/s12272-014-0489-z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Folic acid-decorated self-organized nanoparticles were fabricated to target folate receptor of cancer cells. Doxorubicin (DOX) was conjugated with carboxyl group of dextran backbone using succinic anhydride (DexSU-DOX). DOX-loaded self-organized nanoparticles were prepared by complexation with folic acid-grafted chitosan (ChitoFA) and DexSU-DOX. Nanoparticles in the aqueous environment have spherical shapes with average size less than 100 nm and their sizes were increased by coated with ChitoPEG or ChitoFA. At cell culture study with KB cells, ChitoFA coated nanoparticles (FADex NP) revealed folate-receptor mediated endocytosis to cancer cells and cell viability was significantly changed by folate receptor targeting. Tumor xenograft model of KB cells also showed similar results, i.e. FAdex NP efficiently inhibited growth of tumor compared to the treatment group with blocking of folate receptor. These results indicated that DOX-loaded nanoparticles of FADex NP are promising vehicle for anticancer drug targeting.
引用
收藏
页码:1546 / 1553
页数:8
相关论文
共 23 条
[1]   Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin [J].
Akiyoshi, K ;
Kobayashi, S ;
Shichibe, S ;
Mix, D ;
Baudys, M ;
Kim, SW ;
Sunamoto, J .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) :313-320
[2]   Chitosan nanoparticles for oral drug and gene delivery [J].
Bowman, Katherine ;
Leong, Kam W. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (02) :117-128
[3]  
Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
[4]  
Cadée JA, 2000, J BIOMED MATER RES, V50, P397
[5]  
Dosio F, 2010, CURR OPIN INVEST DR, V11, P1424
[6]   BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES [J].
GREF, R ;
MINAMITAKE, Y ;
PERACCHIA, MT ;
TRUBETSKOY, V ;
TORCHILIN, V ;
LANGER, R .
SCIENCE, 1994, 263 (5153) :1600-1603
[7]   Antitumor activity of dextran derivatives immobilizing platinum complex (II) [J].
Ichinose, K ;
Tomiyama, N ;
Nakashima, M ;
Ohya, Y ;
Ichikawa, M ;
Ouchi, T ;
Kanematsu, T .
ANTI-CANCER DRUGS, 2000, 11 (01) :33-38
[8]   Polysaccharide colloidal particles as delivery systems for macromolecules [J].
Janes, KA ;
Calvo, P ;
Alonso, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :83-97
[9]   All-trans retinoic acid-incorporated nanoparticles of deoxycholic acid-conjugated dextran for treatment of CT26 colorectal carcinoma cells [J].
Jeong, Young Il ;
Chung, Kyu Don ;
Kim, Da Hye ;
Kim, Yoon Hyuk ;
Lee, Yeon Soo ;
Choi, Ki Choon .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 :485-493
[10]   Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro [J].
Jeong, Young-Ii ;
Jin, Shu-Guang ;
Kim, In-Young ;
Pei, Jian ;
Wen, Min ;
Jung, Tae-Young ;
Moon, Kyung-Sub ;
Jung, Shin .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 79 (01) :149-155